855 related articles for article (PubMed ID: 25437566)
1. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.
Brehme M; Voisine C; Rolland T; Wachi S; Soper JH; Zhu Y; Orton K; Villella A; Garza D; Vidal M; Ge H; Morimoto RI
Cell Rep; 2014 Nov; 9(3):1135-50. PubMed ID: 25437566
[TBL] [Abstract][Full Text] [Related]
2. A systematic atlas of chaperome deregulation topologies across the human cancer landscape.
Hadizadeh Esfahani A; Sverchkova A; Saez-Rodriguez J; Schuppert AA; Brehme M
PLoS Comput Biol; 2018 Jan; 14(1):e1005890. PubMed ID: 29293508
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
4. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
Sinnige T; Yu A; Morimoto RI
Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
[TBL] [Abstract][Full Text] [Related]
5. Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides.
Truttmann MC; Pincus D; Ploegh HL
Proc Natl Acad Sci U S A; 2018 May; 115(22):E5008-E5017. PubMed ID: 29760078
[TBL] [Abstract][Full Text] [Related]
6. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
7. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
8. Protein folding, misfolding and quality control: the role of molecular chaperones.
Papsdorf K; Richter K
Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
[TBL] [Abstract][Full Text] [Related]
9. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
Brehme M; Voisine C
Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum proteostasis impairment in aging.
Martínez G; Duran-Aniotz C; Cabral-Miranda F; Vivar JP; Hetz C
Aging Cell; 2017 Aug; 16(4):615-623. PubMed ID: 28436203
[TBL] [Abstract][Full Text] [Related]
11. Proteostasis impairment in protein-misfolding and -aggregation diseases.
Hipp MS; Park SH; Hartl FU
Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
[TBL] [Abstract][Full Text] [Related]
12. Chaperone networks: tipping the balance in protein folding diseases.
Voisine C; Pedersen JS; Morimoto RI
Neurobiol Dis; 2010 Oct; 40(1):12-20. PubMed ID: 20472062
[TBL] [Abstract][Full Text] [Related]
13. Proteostasis of Huntingtin in Health and Disease.
Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
[TBL] [Abstract][Full Text] [Related]
14. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
[TBL] [Abstract][Full Text] [Related]
15. Vulnerability of newly synthesized proteins to proteostasis stress.
Xu G; Pattamatta A; Hildago R; Pace MC; Brown H; Borchelt DR
J Cell Sci; 2016 May; 129(9):1892-901. PubMed ID: 27026526
[TBL] [Abstract][Full Text] [Related]
16. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
17. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
18. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
Hervás R; Oroz J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
[TBL] [Abstract][Full Text] [Related]
20. A genetic screening strategy identifies novel regulators of the proteostasis network.
Silva MC; Fox S; Beam M; Thakkar H; Amaral MD; Morimoto RI
PLoS Genet; 2011 Dec; 7(12):e1002438. PubMed ID: 22242008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
